$484 Million is the total value of Samsara BioCapital, LLC's 56 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| KDNY | CHINOOK THERAPEUTICS INC | $119,497,707 | -11.6% | 5,161,888 | 0.0% | 24.70% | -15.1% | |
| New | MINERALYS THERAPEUTICS INC | $70,773,193 | – | 4,519,361 | +100.0% | 14.63% | – | |
| SRRK | SCHOLAR ROCK HLDG CORP | $36,790,624 | -11.6% | 4,598,828 | 0.0% | 7.60% | -15.1% | |
| Sell | ARCELLX INC | $28,024,129 | -5.5% | 909,579 | -5.0% | 5.79% | -9.3% | |
| GRPH | GRAPHITE BIO INC | $20,725,319 | -26.2% | 8,459,314 | 0.0% | 4.28% | -29.1% | |
| RAIN | RAIN ONCOLOGY INC | $19,758,098 | +9.2% | 2,260,652 | 0.0% | 4.08% | +4.9% | |
| ISEE | Sell | IVERIC BIO INC | $16,710,696 | -3.4% | 686,835 | -15.0% | 3.45% | -7.2% |
| New | ZYMEWORKS INC | $14,651,010 | – | 1,620,687 | +100.0% | 3.03% | – | |
| VRNA | VERONA PHARMA PLCsponsored ads | $13,955,620 | -23.2% | 695,001 | 0.0% | 2.88% | -26.2% | |
| AVDL | Buy | AVADEL PHARMACEUTICALS PLCsponsored adr | $12,910,186 | +173.4% | 1,409,409 | +113.7% | 2.67% | +162.6% |
| NKTX | NKARTA INC | $10,181,524 | -40.7% | 2,868,035 | 0.0% | 2.10% | -43.1% | |
| Sell | HILLEVAX INC | $10,081,019 | -1.2% | 609,862 | -0.0% | 2.08% | -5.1% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $8,604,440 | +8.6% | 640,688 | 0.0% | 1.78% | +4.2% | |
| PEPGEN INC | $7,962,342 | -8.5% | 651,050 | 0.0% | 1.65% | -12.1% | ||
| STRO | SUTRO BIOPHARMA INC | $7,741,175 | -42.8% | 1,675,579 | 0.0% | 1.60% | -45.1% | |
| CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $6,520,884 | +24.2% | 1,693,736 | 0.0% | 1.35% | +19.3% | |
| RYTM | RHYTHM PHARMACEUTICALS INC | $6,160,027 | -38.7% | 345,293 | 0.0% | 1.27% | -41.2% | |
| DICE THERAPEUTICS INC | $5,809,446 | -8.2% | 202,773 | 0.0% | 1.20% | -11.8% | ||
| PRIME MEDICINE INC | $5,784,739 | -33.8% | 470,304 | 0.0% | 1.20% | -36.4% | ||
| ACRS | ACLARIS THERAPEUTICS INC | $5,632,023 | -48.6% | 696,171 | 0.0% | 1.16% | -50.7% | |
| AMYT | AMRYT PHARMA PLCsponsored ads | $4,442,745 | +99.7% | 304,715 | 0.0% | 0.92% | +91.6% | |
| JANX | JANUX THERAPEUTICS INC | $4,361,009 | -8.1% | 360,414 | 0.0% | 0.90% | -11.8% | |
| IMCR | IMMUNOCORE HLDGS PLCads | $4,002,811 | -13.4% | 80,963 | 0.0% | 0.83% | -16.8% | |
| LIFE | New | ATYR PHARMA INC | $3,675,000 | – | 1,750,000 | +100.0% | 0.76% | – |
| LYRA | LYRA THERAPEUTICS INC | $3,572,275 | -36.0% | 1,777,251 | 0.0% | 0.74% | -38.6% | |
| IMTX | IMMATICS N.V | $3,415,500 | -20.8% | 495,000 | 0.0% | 0.71% | -23.9% | |
| INZY | New | INOZYME PHARMA INC | $2,890,252 | – | 504,407 | +100.0% | 0.60% | – |
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $2,626,202 | -37.9% | 196,425 | 0.0% | 0.54% | -40.3% | |
| TANGO THERAPEUTICS INC | $2,488,500 | -45.5% | 630,000 | 0.0% | 0.51% | -47.7% | ||
| DBTX | DECIBEL THERAPEUTICS INC | $2,420,920 | +47.3% | 801,629 | 0.0% | 0.50% | +41.2% | |
| TERN | TERNS PHARMACEUTICALS INC | $2,395,800 | +16.3% | 202,348 | 0.0% | 0.50% | +11.7% | |
| SYROS PHARMACEUTICALS INC | $2,353,472 | -25.6% | 881,450 | 0.0% | 0.49% | -28.6% | ||
| IGMS | IGM BIOSCIENCES INC | $2,125,083 | -19.2% | 154,664 | 0.0% | 0.44% | -22.4% | |
| IO BIOTECH INC | $1,890,819 | -18.5% | 1,008,437 | 0.0% | 0.39% | -21.6% | ||
| ELEV | ELEVATION ONCOLOGY INC | $1,578,074 | +100.0% | 830,565 | 0.0% | 0.33% | +91.8% | |
| BOLT | BOLT BIOTHERAPEUTICS INC | $1,458,323 | +6.9% | 1,049,153 | 0.0% | 0.30% | +2.4% | |
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1,411,200 | -16.0% | 480,000 | 0.0% | 0.29% | -19.3% | |
| VTVT | VTV THERAPEUTICS INCcl a | $1,321,164 | +21.9% | 1,635,509 | 0.0% | 0.27% | +17.2% | |
| ALXO | ALX ONCOLOGY HLDGS INC | $1,187,793 | -59.9% | 262,786 | 0.0% | 0.24% | -61.5% | |
| TIL | INSTIL BIO INC | $1,181,695 | +4.9% | 1,788,280 | 0.0% | 0.24% | +0.8% | |
| VIRX | VIRACTA THERAPEUTICS INC | $1,096,637 | +8.9% | 689,709 | 0.0% | 0.23% | +4.6% | |
| ALLK | ALLAKOS INC | $765,796 | -47.1% | 172,089 | 0.0% | 0.16% | -49.4% | |
| EQ | EQUILLIUM INC | $449,345 | -31.1% | 615,541 | 0.0% | 0.09% | -33.6% | |
| ASTRIA THERAPEUTICS INC | $332,500 | -10.7% | 25,000 | 0.0% | 0.07% | -13.8% | ||
| ALVR | ALLOVIR INC | $324,404 | -23.2% | 82,336 | 0.0% | 0.07% | -26.4% | |
| BCEL | Sell | ATRECA INC | $299,623 | -5.7% | 262,827 | -33.8% | 0.06% | -8.8% |
| LPTX | New | LEAP THERAPEUTICS INC | $287,653 | – | 846,038 | +100.0% | 0.06% | – |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $256,279 | -35.5% | 883,720 | 0.0% | 0.05% | -38.4% | |
| SCIENCE 37 HOLDINGS INC | $253,440 | -32.2% | 900,000 | 0.0% | 0.05% | -35.0% | ||
| New | KALA PHARMACEUTICALS INC | $180,961 | – | 12,024 | +100.0% | 0.04% | – | |
| SURROZEN INC | $180,600 | +3.5% | 300,000 | 0.0% | 0.04% | -2.6% | ||
| NVAX | NOVAVAX INC | $147,221 | -32.6% | 21,244 | 0.0% | 0.03% | -36.2% | |
| KRON | KRONOS BIO INC | $114,071 | -9.9% | 78,131 | 0.0% | 0.02% | -11.1% | |
| NGM | NGM BIOPHARMACEUTICALS INC | $55,770 | -18.7% | 13,669 | 0.0% | 0.01% | -20.0% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $16,000 | -17.0% | 133,333 | 0.0% | 0.00% | -25.0% | |
| SURROZEN INC*w exp 08/01/203 | $10,000 | +81.5% | 99,999 | 0.0% | 0.00% | +100.0% | ||
| NVAX | Exit | NOVAVAX INCcall | $0 | – | -23,400 | -100.0% | -0.05% | – |
| KALA | Exit | KALA PHARMACEUTICALS INC | $0 | – | -12,024 | -100.0% | -0.10% | – |
| SWTX | Exit | SPRINGWORKS THERAPEUTICS INC | $0 | – | -22,204 | -100.0% | -0.12% | – |
| ALBO | Exit | ALBIREO PHARMA INC | $0 | – | -100,000 | -100.0% | -0.46% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -1,620,687 | -100.0% | -2.74% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2023-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Intercept Pharmaceuticals Inc | 20 | Q3 2023 | 24.0% |
| ALLAKOS INC | 20 | Q3 2023 | 23.0% |
| SUTRO BIOPHARMA INC | 20 | Q3 2023 | 10.1% |
| SYROS PHARMACEUTICALS INC | 16 | Q3 2022 | 11.6% |
| ATRECA INC | 16 | Q1 2023 | 7.4% |
| IVERIC BIO INC | 15 | Q2 2023 | 5.5% |
| ACLARIS THERAPEUTICS INC | 15 | Q3 2023 | 4.8% |
| RHYTHM PHARMACEUTICALS INC | 15 | Q3 2023 | 2.4% |
| ODONATE THERAPEUTICS INC | 14 | Q1 2022 | 14.9% |
| SPRINGWORKS THERAPEUTICS INC | 14 | Q4 2022 | 12.1% |
View Samsara BioCapital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-08-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR/A | 2023-02-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Samsara BioCapital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.